Profit & Loss

  • Company Name :
Bafna Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532989
  • NSE Symbol:
  • BAFNAPH
  • P/E(TTM):
  • 25.21
  • ISIN Demat:
  • INE878I01022
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 4.25
  • Book Value(₹):
  • 35.85
  • Market Cap(₹Cr.):
  • 253.48
  • Face Value(₹):
  • 10.00
Particulars Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
INCOME :          
Sales Turnover 145.86 152.47 115.35 85.14 71.22
Excise Duty - - - - -
Net Sales 145.86 152.47 115.35 85.14 71.22
Other Income 2.74 3.52 3.27 1.70 0.75
Stock Adjustments -6.45 4.85 2.91 1.77 -2.95
Total Income 142.15 160.84 121.53 88.61 69.02
EXPENDITURE :          
Raw Materials 74.49 91.58 65.98 41.70 33.58
Power and Fuel Cost 7.72 6.73 5.31 3.93 2.95
Other Manufacturing Expenses 14.83 13.83 8.68 7.72 6.72
Selling and Administration Expenses 9.37 13.98 5.39 6.92 2.67
Miscellaneous Expenses 2.94 1.06 1.33 2.19 0.07
Employee Benefit Expenses 21.03 19.03 15.87 14.65 11.98
Less: Preoperative Expenditure - - - - -
Total Expenses - - - - -
Operating Profit 11.77 14.63 18.99 11.50 11.04
Interest 2.73 2.29 2.04 0.79 0.74
Gross Profit 9.04 12.34 16.95 10.71 10.30
Depreciation 4.89 5.00 5.33 5.49 4.48
Profit Before Tax 4.15 7.34 11.62 5.22 5.82
Current Tax - - 0.28 - -
Fringe Benefit tax - - - - -
Deferred Tax - - - - -
Reported Net Profit 4.15 7.35 11.34 5.22 5.83
Extraordinary Items -2.22 0.07 0.20 -2.16 -
Adjusted Net Profit 6.37 7.28 11.14 7.38 5.83
Adjustment below Net Profit -0.19 0.04 0.15 -0.02 -
Profit/Loss Balance carried down -47.10 -54.48 -65.97 -71.17 -76.99
Statutory Appropriations - - - - -
Appropriations - - - - -
P & L Balance carried down -43.13 -47.10 -54.48 -65.97 -71.17
Dividend - - - - -
Preference Dividend - - - - -
Equity Dividend (%) - - - - -
Dividend Per Share(Rs) - - - - -
Earnings Per Share-Unit Curr 1.76 3.11 4.79 2.21 2.46
Earnings Per Share(Adj)-Unit Curr 1.76 3.11 4.79 2.21 2.46
Book Value 35.85 34.17 31.05 26.19 24.00
Book Value(Adj)-Unit Curr 35.85 34.17 31.05 26.19 24.00